Branched Stent Grafts Market Size, Share, Trend, and Growth Report 2032

Branched Stent Grafts Market Insights

Zion Market Research has published a report on the global Branched Stent Grafts Market, estimating its value at USD 596.96 Million in 2023, with projections indicating that it will reach USD 1941.29 Million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 14% over the forecast period 2024-2032.

The report explores the factors fueling market growth, the hitches that could hamper this expansion, and the opportunities that may arise in the Branched Stent Grafts Market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

Request Free Sample

Global Branched Stent Grafts Market Size

The report offers an assessment and analysis of the Branched Stent Grafts market on a global and regional level. The study offers a comprehensive assessment of the market competition, constraints, revenue estimates, opportunities, evolving trends, and industry-validated data. The report provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Million).

Branched Stent Grafts Market: Overview

Endovascular pararenal repair and thoracoabdominal aortic aneurysm repair with branched stent grafts has met with huge success with low morbidity. Furthermore, patient-related branched stent grafts have the benefit of fitting patient anatomy and this has culminated in massive demand for branched stent grafts. In addition to this, surge in proportion of endovascular aneurysm repair methods and technological breakthroughs along with need for improving quality of patient care has resulted in the massive acceptance of branched stent grafts in the healthcare sector.

Branched Stent Grafts Market: Growth Drivers

Rise in aging population prone to risk of developing aortic aneurysms will create new growth avenues for the branched stent grafts market over the forthcoming years. Escalating demand for EVAR methods has enhanced need for stent grafts, thereby driving branched stent grafts market trends. In addition to this, massive product approvals by regulatory authorities such as the U.S. FDA will culminate in humungous industry expansion. Increasing use of branched stent grafts has resulted in low rate of mortality and this has enhanced product penetration in medical sector, thereby adding substantially to size of branched stent grafts market. Need for eliminating delays in medical treatment along with implementation of government protocols to standardize production of equipment & implantation procedures in healthcare sector will embellish growth of branched stent grafts market in near future.

Furthermore, favorable clinical outcomes and anatomic feasibility will prompt expansion of the branched stent grafts market during the forecasting years. Massive demand for creating branched stent graft for endovascular repairing of aortic arch aneurysms will boost growth of the branched stent grafts market. Better sheaths, commercial manufacture, and better-covered stents have assisted in extending use of branched stent grafts to wide range of aneurysms. This, in turn, will culminate into the humungous expansion of branched stent grafts industry over forecast timeframe.

Request Free Sample

Regional Landscape

North America To Make Notable Contributions Toward Overall Market Size By 2032

The regional market growth from 2021 to 2032 can be credited to easy access to strong healthcare infrastructure facilities along with favorable compensation policies in the sub-continent. In addition to this, the presence of major industry players in North America is slated to contribute notably towards market profitability in region over the forecast period. Technological innovations in medical equipment will further drive regional market space during the forecast timeframe.

Branched Stent Grafts Market: Report Scope

Competitive Landscape

Key players influencing the business landscape and profiled in the report include

• Medtronic Corporation
• Eucatech AG
• Biotronik
• Endocor GmbH
• Alvimedica
• Abbot Laboratories
• Merit Medical Systems, Inc.
• Cardinal Health, Inc.
• Cook Medical
• Boston Scientific Corporation, and Terumo Corporation

The Global Branched Stent Grafts market is segmented as follows:

By Type

• Iliac Stent

By Application

• EVAR

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa